Immatics N.V.

closed
IMTXSEC EDGARCIK: 0001809196|ARYA Sciences Holdings•Biotechnology

Capital Structure & Economics

Trust SizeN/A
Unit Price$10.00
Warrant Coverage-
Sponsor Promote20%

Implied Equity Architecture

Public Trust AllocationN/A
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedJul 31, 2020
SearchingTarget Pending
Maturation Wall
N/A

Announced Target / M&A

  • Target CompanyImmatics Biotechnologies GmbH
  • SectorBiotechnology
  • Announced Deal Size$350,000,000

Board & Officers

  • Harpreet SinghCEO
  • Michael G. AtiehDirector
  • Paul R. CarterDirector
  • Peter ChambréDirector
  • Christof HettichDirector
  • Heather L. MasonDirector
  • Adam Stone(6)
    Director
  • Harpreet Singh, Ph.D.Director
  • Thomas UlmerDirector
  • Cedrik Britten, M.D.Director
  • Carsten Reinhardt, M.D., Ph.D.Director
  • Toni Weinschenk, Ph.D.Director
  • Rainer Kramer, Ph.D.Director
  • Steffen Walter, Ph.D.Director
  • Christof Hettich, L.L.D.Director
  • Joseph Edelman(6)
    Director
  • Michael Altman(6)
    Director
  • Kevin Conroy(4)
    Director
  • Dr. Todd Wider(2)
    Director
  • Dr. David Hung(2)
    Director

Advanced Structuring Terms

Target SectorsBiotechnology

Syndicate & Advisors

  • ARYA Sciences Acquisition Corp.LEAD

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction